Development and validation of RP-HPLC method for quantitative estimation of related substances in gatifloxacin drug substance

The analysis of improved RP-HPLC method for the separation and quantification of Gatifloxacin and its impurities are described. Samples are analysed by means of reverse phase (RP-HPLC) using an Zorbax Eclipse C18, 50 x 4.6 mm5µm and the mobile phase consists of two Channels A and B.Channel-A:0.1% Tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Alladi Devi Sravanthi, Ponnuri Bharath, Peddi Kiranmayi, Dittakavi Ramachandran
Format: Article
Language:English
Published: Engineering Society for Corrosion, Belgrade 2024-06-01
Series:Zaštita Materijala
Subjects:
Online Access:https://www.zastita-materijala.org/index.php/home/article/view/1148
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The analysis of improved RP-HPLC method for the separation and quantification of Gatifloxacin and its impurities are described. Samples are analysed by means of reverse phase (RP-HPLC) using an Zorbax Eclipse C18, 50 x 4.6 mm5µm and the mobile phase consists of two Channels A and B.Channel-A:0.1% Trifluoroacetic acid buffer   and Channel-B:Acetonitrile. The flow rate is 1.0 ml/min. The column temperature was maintained at 35°C and sample temperature was maintained at 25°C, injection volume 10µLand wavelength fixed at 220nm UV-detection. The developed LC method was validated with respect to specificity, precision, linearity, ruggedness and robustness. Validation study compared as per ICH guideline.
ISSN:0351-9465
2466-2585